Regeneron offers funding for nonprofit research, medical education, and collaborative science initiatives to advance medicine and healthcare innovation.
Regeneron funds independent medical education and research conferences to advance scientific and medical knowledge through professional development and educational initiatives.
Regeneron Pharmaceuticals' Third-party Research Requests Program funds independent, investigator-initiated scientific research projects that prioritize scientific rigor and regulatory compliance.
Innovation in Regulatory Science supports academic investigators developing tools, standards, and approaches to strengthen regulatory decisions and protect human health and safety.
Health & Medicine - Starr Foundation supports medical centers and researchers through pioneering research, collaborative science, and facility improvements to advance discoveries and improve patient care.
Medical Research Support backs third-party investigators studying Illumina products and technology in four clinical areas to advance genomics research and its use in areas of clinical need.